Stay updated with breaking news from Equity Consideration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun...
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure
Cambridge Cognition to acquire eClinicalHealth Limited
TEL AVIV, ISRAEL / ACCESSWIRE / January 17, 2022 / A2Z Smart Technologies Corp. ("A2Z" or the "Company") (NASDAQ:AZ)(TSXV:AZ), today announced that it has entered into a share purchase agreement (the "SPA")
Press release content from Accesswire. The AP news staff was not involved in its creation.